Skip to main content

Non-inflammatory Degenerative Joint Disease

0
Pipeline Programs
2
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Zimmer Biomet
Zimmer BiometFL - Jacksonville
3 programs
A Clinical Investigation of the M2a- 38™ Hip SystemN/A1 trial
A Clinical Investigation of the M2a- Taper™ Hip SystemN/A1 trial
BC Study of G7 Cup and Compatible Femoral StemsN/A1 trial
Active Trials
NCT00698503Terminated190Est. Dec 2008
NCT00698633Terminated43Est. Dec 2008
NCT03456622Active Not Recruiting230Est. Dec 2030
Stryker
StrykerCA - San Jose
2 programs
Stryker Triathlon Primary Total Knee SystemN/A1 trial
Tornier Perform™ Reversed MonoPostN/A1 trial
Active Trials
NCT02650284Terminated18Est. Mar 2019
NCT07764614Recruiting150Est. Aug 2031

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
StrykerTornier Perform™ Reversed MonoPost
Zimmer BiometBC Study of G7 Cup and Compatible Femoral Stems
StrykerStryker Triathlon Primary Total Knee System
Zimmer BiometA Clinical Investigation of the M2a- 38™ Hip System
Zimmer BiometA Clinical Investigation of the M2a- Taper™ Hip System

Clinical Trials (5)

Total enrollment: 631 patients across 5 trials

NCT07764614StrykerTornier Perform™ Reversed MonoPost

Tornier Perform™ Reversed Monopost Study

Start: Oct 2026Est. completion: Aug 2031150 patients
N/ARecruiting
NCT03456622Zimmer BiometBC Study of G7 Cup and Compatible Femoral Stems

BC Study of G7 Cup and Compatible Femoral Stems

Start: Nov 2015Est. completion: Dec 2030230 patients
N/AActive Not Recruiting
NCT02650284StrykerStryker Triathlon Primary Total Knee System

A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot

Start: Aug 2015Est. completion: Mar 201918 patients
N/ATerminated
NCT00698503Zimmer BiometA Clinical Investigation of the M2a- 38™ Hip System

A Clinical Investigation of the M2a- 38™ Hip System

Start: Jan 2002Est. completion: Dec 2008190 patients
N/ATerminated
NCT00698633Zimmer BiometA Clinical Investigation of the M2a- Taper™ Hip System

A Clinical Investigation of the M2a- Taper™ Hip System

Start: Dec 2001Est. completion: Dec 200843 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 631 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.